An arrest in laying associated with either a polyovarian follicle (POF) or a polycystic ovarian follicle (PCOF) syndrome has been reported in turkey hens photostimulated at an early age with a constant-light photoperiod. Hens expressing the POF or PCOF syndrome had stopped laying for several weeks, but the ovary contained an increased number of mature-size and larger follicles (POF hens), which were cystic (PCOF) in some of the hens. Hens with the POF or PCOF syndrome had plasma progesterone (P 4 ) concentrations that were relatively high and without surges. We hypothesized that high plasma P 4 concentrations may block ovulatory surges of LH but not the growth or maintenance of hierarchical follicles leading to development of the POF or PCOF syndrome in turkey hens. In the first six studies, hens were photostimulated with either a 14L:10D or a 24L:0D photoperiod and, after laying for 1-38 wk, were then injected daily for up to 14 days with P 4 (up to 1.50 mg kg ؊1 day
INTRODUCTION
An arrest in laying associated with a polyovarian follicle (POF) or polycystic ovarian follicle (PCOF) syndrome has been observed in Egg line turkey hens [1, 2] . In these studies, hens were divided into three different classes based on laying history and types of ovarian follicles present at necropsy. Laying hens had a normal laying history, and their ovary had only hierarchical follicles arranged in a single follicular hierarchy. Arrested-laying POF hens had ceased laying for 2-3 wk, but their ovary contained hierarchical follicles arranged in a single follicular hierarchy as well as five or more mature (F 1 ) or slightly heavier-weight follicles. Arrested-laying PCOF hens had ceased laying for 2-3 wk, but their ovary contained hierarchical follicles arranged in a single follicular hierarchy as well as five or more mature or heavier-weight follicles, some of which were cystic. Some of the laying, POF, and PCOF hen ovaries also contained atretic follicles. The oviducts of the POF and PCOF hens were similar in weight to those of the laying hens, although these hens had not laid eggs for up to 3 wk [1, 2] . Hens of both POF and PCOF classes would evert their oviducts on application of abdominal pressure as applied to turkey hens during artificial insemination. Many of the POF and PCOF hens also retained hard-shelled eggs in the uterus for several days without ovipositions. The commercial turkey industry utilizes heavy-weight, sire-line males crossed with medium-weight, dam-line females to produce poults. Egg production rate of the sire-line females is generally much lower than that for the dam-line females [3] . The ovaries of sire-line females, however, contain an increased number of hierarchical follicles [4] [5] [6] [7] , which is associated with an increase in multiple follicular hierarchy sets, in comparison to dam-line females [3] [4] [5] [6] [7] . The number and type of ovarian follicles in hens expressing POF or PCOF syndrome were thus different from those in sire-line hens. The former had an increase in the number of mature and larger-size follicles and a normal hierarchy, whereas the latter had an increase in the incidence of multiple follicular hierarchy sets within the hierarchy.
In POF and PCOF hens, the concentration of LH was relatively low and without ovulatory surges; the concentration of progesterone (P 4 ) was relatively high, approaching levels observed during ovulatory surges but without ovulatory surges; and the concentration of estradiol-17␤ (E 2 ) was similar to that in laying hens [1] . These plasma concentrations and peripheral patterns of LH, P 4 , and E 2 in the POF and PCOF hens are similar to concentrations reported for laying chicken hens that had been treated with eCG for several days [8] [9] [10] . Chicken and turkey hens treated with eCG [11, 12] also have an arrest in egg production, and their ovaries contain numerous mature-size follicles similar to those in POF or PCOF hens [1, 2] . Multiple mature-size follicles of hens injected with eCG could be ovulated by injection of LH [13, 14] or chicken anterior pituitary extract [15] . Hens treated with eCG did not ovulate, however, after injection of P 4 [16] . Acute administration of exogenous LH to hypophysectomized laying hens [7] and intact laying hens [17] , of P 4 to intact laying hens [18] [19] [20] , or of GnRH to intact laying hens [21] has been shown to induce premature ovulation if administered when plasma levels of LH and P 4 had been at baseline levels between surges for several hours. In these studies, only the largest and most mature follicle was ovulated after hormonal injection.
The effect of continuously high P 4 levels on serial ovulations has received little recent attention, but laying chicken hens treated with daily injections of P 4 for up to 1 wk ceased egg production [13] . Chronic treatment with P 4 has been reported to depress egg production in chickens [22] and turkeys [23] . Also, turkey hens treated with P 4 implants, either with or without estrogen treatment, had a greatly decreased egg production rate [24] . Thus, chronic treatment with P 4 has been reported to depress the rate of egg production in both turkeys and chickens.
Age when photostimulated and photoperiod have been shown to be important variables concerning the incidence of POF and PCOF syndromes [2] in Egg line turkey hens. The incidence of the POF and PCOF syndromes was greater when photosensitive turkey hens were photostimulated at relatively young ages (age, Ͻ31 wk) and when exposed to a constant-light photoperiod of 24L:0D in comparison to a diurnal photoperiod of 14L:10D. Thus, age when photostimulated and photoperiod are associated with the incidence of POF and PCOF syndromes.
Acute injection of P 4 in laying chicken hens can arrest the movement of an egg in the oviduct [25, 26] . Chronic treatment of laying quail hens with P 4 can result in fully formed eggs being retained in the uterus for several weeks [27] . These studies indicate that continuously high P 4 levels might inhibit uterine smooth muscle contractions and, thus, block ovipositions.
Acute injection of P 4 might also feed back negatively on the ability of the hypothalamus to secrete surges of GnRH or, alternatively, on the ability of the pituitary to secrete surges of LH if surges of GnRH secretion occur. In the present study, we hypothesized that chronic high plasma concentrations of P 4 , resulting from daily injections of the hormone, may block ovulatory surges of LH but not recruitment of follicles into the hierarchy or their development, thus resulting in development of the POF or PCOF syndrome. Because the POF and PCOF syndromes have only been observed relatively early during egg production, and at a higher rate with a constant-light photoperiod, we also hypothesized that the age of the hen, the duration of egg production, and the photoperiod may alter the response to P 4 injection. The objectives of the present experiments were to determine the effects of P 4 injection, photoperiod, and duration of egg production on ovarian and oviductal morphology, egg production, and incidence of POF and PCOF syndromes in turkey hens.
MATERIALS AND METHODS

Birds and Experiments
Turkey hens of the Egg line [28] were exposed to short-day lighting of 6L:18D at 16 wk of age to induce photosensitivity and delay puberty. Age when photostimulated, photoperiod used for photostimulation, duration of egg production when P 4 injections began, duration of P 4 injections, dosages of P 4 injected, and duration of the postinjection period before experiment termination and necropsy are given in Table 1 for the eight experiments. When photostimulated, the hens were housed in light-tight rooms in individual cages (60 ϫ 60 ϫ 80 cm) bedded with wood shavings [1] except in experiments 2 and 6. The hens used in experiments 2 and 6 were initially housed in floor pens for 36 wk of egg production [28] and then in the cages for 1 wk before initiation of injections. Light intensity varied from 20 lux from the bottom tier inside the cages to 100 lux at the top tier outside the cages. Progesterone (Sigma, St. Louis, MO) was injected s.c. daily at the dorsal region of the neck. Progesterone was prepared in canola oil at dilutions so that 0.20 ml was injected for each 1.00 kg of body weight.
During injection periods and for the 3-wk postinjection periods of experiments 7 and 8, the hens were checked daily for oviposited eggs and digitally palpated for uterine eggs. In the various experiments, egg production was also measured for 7-14 days before initiation of P 4 injections. Eggs were stored at 4ЊC until processed, within 1 wk of laying, to measure egg weight and yolk weight. Blood samples (1.5 ml) were collected at various times during experiments 2, 6, and 8. Blood samples were usually taken just before a daily P 4 injection during the period of injections. In experiment 6, however, samples were additionally collected at various times after a single daily injection, and in experiment 8, samples were collected weekly for the 3 wk between the last injections and experiment termination. All animal procedures were approved by the Institutional Animal Care and Use Committee (Protocol No. 01-AG001).
Morphological Measurements
Hens were killed by an overdose of pentobarbital and necropsied at the end of the P 4 injections (experiments 1-6) or 3 wk after the end of the P 4 injections (experiments 7 and 8). At necropsy, the following morphological measurements were made: 1) presence and location of any eggs in the oviduct, 2) weight of the ovary after removal of all yolky follicles heavier than 0.80 g, 3) weight of the oviduct after removal of any eggs, and 4) weight and classification of all follicles heavier than 0.80 g. Follicles were classified as previously described [1, 2] by the following criteria: Type I follicles were turgid, yolky follicles that increased hierarchically in weight from 0.80 to 1.00 g above the mean yolk weight of the last three eggs laid by a hen before necropsy. Type II and type III follicles were turgid, yolky follicles that were heavier than the type I follicles. Type III follicles were differentiated from type I and type II follicles by containing a less viscous, whitish fluid just under the follicle wall, which was interspersed with the viscous yellow yolk. Type III follicles were also whitish in color in comparison to type I and type II follicles. Type I and type II follicles were easily differentiated from type III follicles by puncturing them and examining the extruded contents for the presence of the whitish fluid [1] . Hens were classified as either not expressing or expressing the POF or PCOF syndrome [1, 2] . Laying hens had a normal laying history and an ovary with only type I follicles at autopsy. The POF hens had ceased laying for 2-3 wk, and their ovary had type I and at least five type II follicles at autopsy. The PCOF hens had ceased laying for 2-3 wk, and their ovary had type I and at least five type II and/or type III ovarian follicles at autopsy.
Hormone Assays
Progesterone was assayed as previously described [29] . All samples from individual experiments were assayed in single assays. The mean intraassay coefficient of variation (CV) was 9.5% for a pool of plasma with a mean P 4 concentration of 7.12 ng/ml.
Estradiol-17␤ was assayed as previously described [30] . Only samples from experiment 8 were assayed in a single assay. The mean intraassay CV was 8.7% for a pool of plasma with a mean E 2 concentration of 0.51 ng/ml.
Luteinizing hormone was assayed as previously described [31] ; only samples from experiment 8 were assayed. The mean intraassay CV was 8.5%, and the interassay CV for the two assays was 11.0%, for a pool of plasma with a mean LH concentration of 2.94 ng/ml.
Data Analyses
Egg production and morphological data for experiments 1, 2, 5, and 6 were analyzed by one-way ANOVA for the effect of P 4 dose. Means were separated when appropriate using the Tukey procedure. Egg production and morphological data for experiments 3, 4, 7, and 8 were analyzed by factorial ANOVA. The model included main effects of photoperiod and P 4 dose as well as their interaction. Main-effect means were separated when appropriate using the Tukey procedure. The differences in incidence of the POF and PCOF syndromes in experiments 7 and 8 were examined by chi-square analysis.
The P 4 data from laying hens were first separated into baseline and surge classes as follows: the P 4 concentrations of laying hens were transformed to ln P 4 concentration, and the distribution of ln P 4 concentration was then plotted as a histogram and fitted with a five-degree polynomial. Histograms and polynomial fitting of the data from experiments 2, 6, and 8 are presented in Figure 1 . Note the bimodal distribution of ln P 4 concentration, with a break between the lower (baseline) and the upper (surge) populations at ln P 4 (ng/ml) ϭ 1.6 (4.95 ng/ml) for each experiment. All concentrations of 4.95 ng/ml or less were considered to be baseline concentrations; all concentrations greater than 4.95 ng/ml were considered to be surge concentrations. Hens that had not laid an egg for 2 days or longer were assumed to have baseline (nonsurge) concentrations of P 4 , although some values were greater than 4.95 ng/ml. For experiments 2 and 6, the baseline P 4 concentrations among treatment groups within experimental day were compared using ANOVA, with dosage of P 4 as main effect. In experiment 8, preliminary analyses showed no effect of photoperiod on hormone (LH, P 4 , and E 2 ) concentrations. The data were then regrouped into control and P 4 -injected hens. The P 4 -injected hens were retrospectively divided into two groups: Laying hens were those that stopped laying during P 4 injection but returned to laying before necropsy 3 wk after the last injection, and PCOF hens were those classified as presenting with the PCOF syndrome at necropsy. All P 4 -injected hens fell into one or the other of these two groups. Main-effect means for LH, P 4 , and E 2 analyses were separated using the Tukey procedure when appropriate. All statistical analyses were conducted using the MINITAB (Release 13.1; MINITAB, State College, PA) statistical package.
RESULTS
Experiment 1
Egg production ( 
Experiment 2
Experiment 3
Egg production (Table 4) was not different among P 4 dosage groups or photoperiod groups before initiation of injections, but it declined with the 0.17 mg kg Ϫ1 day Ϫ1 dosage and stopped with the 0.33 and 0.50 mg kg Ϫ1 day Ϫ1 dosages. Photoperiod had no effect on egg production. Treatment with P 4 had no effect on eggs held for 5 days or longer, but more hens photostimulated with the 24L:0D photoperiod than with the 14L:10D photoperiod held eggs.
Oviductal weight was not affected by either P 4 treatment or lighting treatment. Total ovarian yolky follicle number and number of type I follicles were increased in the 0.33 and 0.50 mg kg Ϫ1 day Ϫ1 dosage groups but were not different between photoperiods. The number of type II follicles was increased at the 0.50 mg kg Ϫ1 d Ϫ1 dosage and with the 14L:10D photoperiod. The number of type III follicles was not affected by P 4 injection or photoperiod. None of the hens had developed either POF or PCOF syndrome when necropsied. The number of atretic follicles was lowest in the control group and highest in the 0.33 and 0.50 mg kg Ϫ1 day Ϫ1 dosage groups, but the number was not different between photoperiods. No interactions between P 4 dosages and photoperiods were noted for any of the traits.
Experiments 4-6
Egg production and morphological measurements for experiments 4 and 5 were similar to those for experiment 3 (data not shown). Egg production and morphological measurements for experiment 6 were similar to those for experiment 2 (morphological data not shown). For experiment 6, plasma baseline P 4 concentrations 24 h after injections were associated with dosage (Fig. 2b) , and the concentrations were in agreement with those of experiment 2. On Experimental Day 7, blood was collected 2.5, 6, and 17 h after P 4 injection. For each dosage, plasma concentrations of P 4 peaked at a level approximately 3.3-fold above the baseline P 4 concentration for that dosage between 2.5 and 6 h after injection.
Experiment 7
Egg production (Table 5) was not different between the P 4 -injected and the photoperiod groups before initiation of FIG. 2. Baseline P 4 concentrations of turkey hens. Only baseline samples were included from hens that were laying or had laid within 48 h of sample collection. a) Experiment 2. Blood samples were collected 24 h after P 4 injection except for Day 0, when samples were collected before the first injection. b) Experiment 6. Blood samples were collected 24 h after P 4 injection except for Day 0, when samples were collected before the first injection, and after the Day 7 sample, when additional samples were collected 2.5, 6, and 17 h after injection. P 4 injections, but egg production stopped in the P 4 -injected hens. Photoperiod had no effect on egg production during treatment with P 4 . The control hens continued to lay during the 3 wk after the P 4 treatment ceased. More of the hens treated with P 4 and given the 24L:0D photoperiod held hard-shelled eggs for 5 days or longer than did hens in the other treatment groups. An interaction was noted between P 4 treatment and photoperiod: more of the 24L:0D photoperiod and P 4 -injected hens (83%) held eggs than did hens in the 24L:0D control and in both 14L:10D photoperiod groups (range, 0-16%). Oviductal weights, measured 3 wk after the last P 4 injections, were not affected by P 4 treatment or photoperiod. Total ovarian yolky follicle number was higher with P 4 treatment and in the 24L:0D photoperiod groups. No difference was observed in the number of type I follicles between P 4 dosage or photoperiod groups. The number of type II and type III follicles was greater in the P 4 treatment and 24L:0D photoperiod groups. An interaction was noted between P 4 treatment and photoperiod, with more type II and type III follicles (means 6.8 and 3.7, respectively) present in the P 4 and 24L:0D photoperiod group than in the control and 14L:10D photoperiod groups (ranges of means, 0-2.6 and 0-0.8, respectively). The number of atretic follicles was greater in the P 4 -treated hens, but this number was not affected by photoperiod.
When necropsied, more of the hens treated with P 4 in the 24L:0D photoperiod group had developed PCOF syndrome than did hens treated with P 4 in the 14L:10D photoperiod group (P Յ 0.05), and none of the control hens in either photoperiod had developed POF or PCOF syndrome (Table 6 ). Weight distribution of follicles for a control and a P 4 -injected, PCOF syndrome hen from the 24L:0D photoperiod group are given in Figure 3a and for a control and a P 4 -injected, PCOF syndrome hen from the 14L:10D photoperiod group in Figure 3b . Both control hens had similar patterns of follicle weight distribution, and both PCOF hens had similar patterns of follicle weight distribution.
Experiment 8
Egg production (Table 7) was not different between P 4 or photoperiod groups before initiation of P 4 injections, but it stopped in all but one of the P 4 -injected hens: One of the P 4 -injected hens in the 14L:10D photoperiod group continued laying during the 12 days of injections. Photoperiod had no effect on egg production during P 4 injection. The control hens continued laying during the 3 wk after the P 4 treatment ceased. More of the hens treated with P 4 and given the 24L:0D photoperiod held hard-shelled eggs for 5 days or longer than did hens in the control and 14L:10D photoperiod groups. Oviductal weights, measured 3 wk after the last P 4 injections, were not affected by P 4 treatment or by photoperiod. Total ovarian yolky follicle number was higher with P 4 treatment and in the 24L:0D photoperiod groups. No differences were observed in the number of type I or type II follicles between P 4 treatment or photoperiod groups. The number of type III follicles was greater in the P 4 -injected group, but the number was not different between photoperiod groups. The number of atretic follicles was not affected by P 4 treatment or by photoperiod.
When necropsied, more of the hens in the P 4 -treated and 24L:0D photoperiod group had developed PCOF syndrome compared with hens in the P 4 -treated and 14L:10D photoperiod group (P Յ 0.05) ( Table 6 ). None of the control hens had developed POF or PCOF syndrome when necropsied.
Plasma baseline P 4 concentrations were increased during P 4 injection (Fig. 4a) . For the hens that had developed PCOF syndrome at necropsy 3 wk after last P 4 injections, the level of P 4 remained high until autopsy, whereas in the hens that had returned to laying, the plasma level of P 4 declined to levels similar to those of the control laying hens. More of the hens photostimulated with the 14L:10D than with 24L:0D photoperiod and injected with P 4 resumed laying (Table 6 ). Plasma baseline LH concentrations were minimally affected by either injection of P 4 or laying state of the hens injected with P 4 (Fig. 4b) , but the level tended to be slightly higher in the control laying hens. Plasma E 2 concentrations were minimally affected by either injection of P 4 or laying state of the hens injected with P 4 (Fig. 4c) , but the level tended to be slightly higher in the control laying hens.
DISCUSSION
The POF and PCOF syndromes in Egg line turkey hens have been defined previously [1] . None of the hens injected with P 4 for 7-14 days and then immediately necropsied met these criteria, although some had not laid for 12 days and had held a fully formed egg in the shell gland for 5 days or longer after laying had ceased. An increase in the number of atretic follicles was noted for these hens, suggesting that follicles may enter the hierarchy but become atretic during P 4 injections. Thus, continuous P 4 injection for up to 14 days did not induce either POF or PCOF syndrome, even though it appeared to initiate the process by inducing an arrest in laying without ovarian or oviductal regression. In experiments 7 and 8, it was decided to alter the experimental protocol by waiting for 3 wk after the last P 4 injections to terminate the experiments and necropsy the hens. It was hypothesized that the hens would not resume laying during this postinjection period and that this period without daily injections of P 4 and associated 3.3-fold increases in plasma concentration might allow additional follicles to accumulate in the ovary as type II and type III follicles. It was also hypothesized that continuous lighting would be more effective at inducing the PCOF syndrome than 14L:10D diurnal lighting, because continuous lighting is more effective at inducing the PCOF syndrome in turkey hens younger than those used in the present experiments without P 4 injection [2] . Most of the hens in the 24L:0D photoperiod groups (12 of 13 [92%]) that had stopped laying for at least 10 days had developed the PCOF syndrome at 3 wk after the last daily P 4 injection. Only a few hens in the 14L:10D photoperiod group (3 of 13 [23%]) that had stopped laying for at least 10 days had developed the PCOF syndrome at 3 wk after the last daily P 4 injection. Of the remaining 10 hens in the 14L:10D photoperiod group that had stopped laying for at least 10 days, 7 resumed laying by 3 wk after the last P 4 injection. Thus, injection of P 4 at a dosage of 0.33 mg kg Ϫ1 day Ϫ1 was effective at stopping egg production of hens photostimulated with either photoperiod, but the 24L:0D photoperiod in conjunction with P 4 injection was much more effective at inducing the PCOF syndrome during the 3 wk following P 4 injections. In experiments 7 and 8, the hens had been laying for approximately 6 wk when P 4 injections started but were of different ages (age, 34 and 48 wk, respectively) when photostimulated. The results of the two experiments were similar, indicating that this difference in age at photostimulation had little influence on the ability to induce the PCOF syndrome by injection of P 4 relatively early in the egg production period. The injection of P 4 can thus be considered as an initiator for development of the PCOF syndrome relatively early in the reproductive period, especially in turkey hens photostimulated with the 24L:0D photoperiod.
In turkey hens with either POF or PCOF syndrome, P 4 levels were previously reported [1] to be relatively high and without surges, whereas the LH level was relatively low and without surges. In the present studies, the turkey hens were not serially bled, so the development of these nonsurge patterns of LH and P 4 secretion previously reported for the hens presenting with POF or PCOF remains unknown. Because surges of LH are associated with ovulations, the data suggest that surge secretion of LH is blocked by daily injections of P 4 at dosages of 0.33 mg kg Ϫ1 day
Ϫ1
or greater. The concentrations of FSH were not measured in the current or previous experiments [1] because of the lack of a validated assay for turkey FSH. In chicken hens, E 2 levels increase with FSH treatment [32] , indicating that peripheral levels of E 2 may be closely associated with FSH. It is suggested that FSH secretion did not change with P 4 treatment, because levels of E 2 did not change during P 4 treatment or development of the PCOF syndrome in experiment 8. For laying hens late in the egg production period, the level of E 2 has been reported to decline [33] ; thus, FSH secretion may also be lower at this time. In older hens, a lower rate of FSH secretion may lead to atresia of ovarian follicles during P 4 injection (experiments 2 and 6) instead of ovarian follicle maintenance (experiments 1, 3, 4, and 5) or development of the PCOF syndrome (experiments 7 and 8) subsequent to P 4 injection.
In all the present studies, a P 4 dosage of 0.17 mg kg Ϫ1 , egg production ceased within approximately 2 days in most hens. Thus, the decline in egg production rate was equally sensitive to the dosage of P 4 injected in young hens early during the egg production period as in old hens late during the egg production period. Age when hens were treated, however, did affect other responses to P 4 treatment. In five of the present experiments, hens were photostimulated at 41 wk of age, then injected with P 4 after 1-38 wk of egg production and immediately necropsied. If injected with P 4 at 0.33-1.50 mg kg Ϫ1 day Ϫ1 before reaching 15 wk of egg production, the hens maintained a fully stimulated oviduct and a normal number of type I (i.e., hierarchical) follicles. The ovaries in these hens additionally had a few type II and type III follicles and an increased number of atretic follicles. If the hens were injected at 38 wk of egg production with 0.33 or 0.50 mg kg Ϫ1 day Ϫ1 , their ovaries also had an increased number of atretic follicles. The oviduct had decreased in weight, however, and the ovary had few type I and no type II or type III follicles. It was concluded in the older hens with increased duration of the egg production period that egg production had stopped and that both the ovarian follicles and the oviduct were regressing after 14 days of P 4 injection. In the younger hens, however, the oviduct was maintained at a weight comparable to that of laying hens, whereas the ovary was maintained in a stimulated state that was different from that of laying hens.
Ovulatory surge levels of P 4 in plasma of laying turkey hens range from between approximately 5 and 8 ng/ml, whereas baseline levels between surges range between 1 and 2 ng/ml [1, 34] . The data from experiments 2 and 6 indicate that baseline levels of P 4 24 h after injection were associated with dosage injected and peaked between 2.5-and 6-h postinjection at levels approximately 3.3-fold higher than the baseline associated with each dosage. Concentrations of P 4 24 h after injection of P 4 at dosages of 0.33 or 0.50 mg kg Ϫ1 day Ϫ1 were similar to ovulatory surge levels in laying turkey hens. It has previously been reported [1, 34] in turkey hens that ovulatory surges of LH occur only when P 4 levels have been at baseline for several hours. This suggests that if P 4 does not drop below ovulatory surge levels, then ovulatory surges of LH may be blocked, thereby blocking ovulation. Hens injected with 0.17 mg kg Ϫ1 day Ϫ1 had a level of P 4 24 h after injection that was intermediate (2.9 ng/ml) between baseline and ovulatory surge levels and an egg production rate that was approximately 50% that of control hens. This suggests that if P 4 remains above laying-hen baseline levels but declines to less than ovulatory surge levels between injections, then the interval between ovulatory surges may be longer, resulting in a lower rate of egg production. These effects of P 4 injection on blocking or increasing the interval between ovulatory surges of LH occurred at all ages and durations of egg production studied and, thus, appear to be independent of hen age or duration of egg production.
From these studies, we conclude that PCOF syndrome can be induced early in the reproduction period by photostimulating hens with a 24L:0D photoperiod, injecting them with P 4 for 10-12 days at a dosage of 0.33 mg kg Ϫ1 day Ϫ1 , and then waiting 3 wk for the syndrome to develop. In older hens near the end of their reproductive period, however, injection of P 4 induces both the ovary and the oviduct to regress.
